LINC01164: A Potential Drug Target and Biomarker (G399827)

Target Name: LINC01164

NCBI ID: G399827

LINC01164

Other Name(s): Long intergenic non-protein coding RNA 1164 | long intergenic non-protein coding RNA 1164

LINC01164: A Potential Drug Target and Biomarker

Non-Protein-Coding RNAs (NP-C RNAs) have emerged as a promising source of drug targets and biomarkers due to their diverse functions and novelty. One of the most well-studied NP-C RNAs is LINC01164, which has been shown to play a critical role in various biological processes and has the potential to serve as a drug target or biomarker.

LINC01164 is a long intergenic non-protein-coding RNA (lncRNA) with a length of approximately 230 nucleotides. It is located between the genes ZNF2 and CDKN2, which are involved in various cellular processes such as cell growth, differentiation, and genomic stability ( 1). LINC01164 is composed of a unique sequence: G/C-rich region, a region of variable length non-coding RNA (ncRNA), and a C-rich termination region.

Functional Analysis of LINC01164

LINC01164 has been shown to have various functions in various cellular processes. For example, LINC01164 has been shown to be involved in cell growth and differentiation, as well as in the regulation of cell cycle progression. Additionally, LINC01164 has been shown to play a role in genomic stability, as it has been shown to be involved in the regulation of chromatin remodeling and histone modifications.

Drug Target Potential

The drug targeting potential of LINC01164 is due to its unique structure and various functions. LINC01164 has a unique sequence that allows it to interact with various protein partners, which may provide a target for small molecules or big molecules that can modulate its function. Additionally, LINC01164 is located in a region of the genome that is known for its involvement in various cellular processes, making it a potential target for drugs that can modulate these processes.

Biomarker Potential

LINC01164 has also been shown to have potential as a biomarker in various diseases. For example, LINC01164 has been shown to be involved in the regulation of cell proliferation and has been used as a biomarker for various types of cancer, including breast, ovarian, and prostate cancer. Additionally, LINC01164 has been shown to play a role in the regulation of cellular processes that are involved in aging, such as the regulation of telomere length and the regulation of DNA damage repair.

Conclusion

In conclusion, LINC01164 is a unique and promising NP-C RNA that has been shown to play a critical role in various biological processes. Its unique structure and various functions make it a potential drug target or biomarker. Further research is needed to fully understand the mechanisms of LINC01164 and its potential uses in medicine.

Protein Name: Long Intergenic Non-protein Coding RNA 1164

The "LINC01164 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01164 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets